-
11/03/2025
PhD and postdoc opportunities - March 2025
PhD position within ERC STG project “AUTOMATHIC”Maastricht UniversityThis 5-year interdisciplinary project aims to perform cutting-edge research in developing new methodologies for the automated …
-Read more-
-
26/02/2025
In the literature: February 2025 highlights
Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter!
-Read more-
-
26/02/2025
Open Market Consultation Project 3Dx3C (Digital Twin Disruptive Developement For Complex, Congenital Care)
The Open Market Consultation Project 3Dx3C, issued by the Hospital Universitari Vall d'Hebron, closes on March 7th 2025 at 2:00 PM.
-Read more-
-
26/02/2025
In silico medicine emerges in Greece
On December 21, 2024, Research Professor Georgios S. Stamatakos, a great pioneer of in silico oncology, delivered a lecture in Sparta (Greece) exploring the emergence, evolution, and clinical potential of in silico medicine.
-Read more-
-
26/02/2025
First rules of the Artificial Intelligence Act are now applicable
From 2 February 2025, the first rules under the Artificial Intelligence Act (AI Act) started to apply.
-Read more-
-
26/02/2025
EMA Draft Guidance on Mechanistic Models in Model-Informed Drug Development (MIDD)
The European Medicines Agency (EMA) is preparing to release draft guidance on how to assess and report new mechanistic models, aiming to encourage their wider use in model-informed drug development (MIDD).
-Read more-
-
26/02/2025
2025/26 VPHi Executive Committee
We are thrilled to present the newly elected Executive Committee that will collaborate with the VPHi BoD and staff members in supporting the full adoption of in silico medicine!
-Read more-
-
19/02/2025
My medical choice: From Angelina Jolie to in silico predictive oncology
Angelina Jolie’s 2013 op-ed sparked a global conversation on genetic cancer risks. Today, in silico tools like CancerMate advance personalised oncology, improving breast cancer treatment predictions.
-Read more-